Press release
Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 - By Report, Size, Share, Industry Growth, Forecast To 2033
Proliferative Diabetic Retinopathy (PDR) Market
As per the report, the proliferative diabetic retinopathy (pdr) market size has grown rapidly in recent years. It will grow from $2.16 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The proliferative diabetic retinopathy (pdr) market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market
The rising prevalence of diabetes is expected to propel the growth of the proliferative diabetic retinopathy (PDR) market going forward. Diabetes is a chronic medical condition characterized by elevated glucose (sugar) levels in the blood. Diabetes is the leading cause of proliferative diabetic retinopathy disease, which can be treated by various methods that prevent further damage to the retina and preserve vision. For instance, in 2021, according to the International Diabetes Federation (IDF), a Belgium-based organization, 537 million adults aged between 20-79 are suffering from diabetes (1 in 10 people) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes drives the proliferative diabetic retinopathy (PDR) market.
Innovative Therapies Revolutionize Proliferative Diabetic Retinopathy Treatment Landscape
Major companies operating in the proliferative diabetic retinopathy market continuously focus on developing novel therapies to enhance treatment effectiveness, reduce treatment burden and improve patient outcomes. For example, in June 2022, Biogen, a US-based biotechnology company and Samsung Bioepis, a South Korea-based biotech company, introduced Byooviz (ranibizumab-nuna), the first ophthalmology biosimilar in the US. These products are used to treat patients with diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD) and choroidal neovascularization.
The proliferative diabetic retinopathy (pdr) market covered in this report is segmented -
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy; Intraocular Steroids; Laser Surgery; Vitrectomy
2) By Mode of Administration: Injectables; Oral; Other Mode Of Administrations
3) By Application: Hospitals; Clinics; Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12911&type=discount
Major players in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.
Contents of the report:
1. Executive Summary
2. Proliferative Diabetic Retinopathy (PDR) Market Report Structure
3. Proliferative Diabetic Retinopathy (PDR) Market Trends And Strategies
4. Proliferative Diabetic Retinopathy (PDR) Market - Macro Economic Scenario
5. Proliferative Diabetic Retinopathy (PDR) Market Size And Growth
…..
27. Proliferative Diabetic Retinopathy (PDR) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 - By Report, Size, Share, Industry Growth, Forecast To 2033 here
News-ID: 3616932 • Views: …
More Releases from The Business research company
Next-Gen Biometric Authentication Market Size Forecasted To Achieve $25.99 Billi …
The Next-Gen Biometric Authentication Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Next-Gen Biometric Authentication Market Size and Projected Growth Rate?
The market size for next-generation biometric authentication has seen an impressive increase in recent times. The market is projected to expand from…
Rising Cases Of Premature Births Driving Growth In The Market Due To Increasing …
The Necrotizing Enterocolitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Necrotizing Enterocolitis Market Size and Its Estimated Growth Rate?
The market for necrotizing enterocolitis has seen a robust expansion in recent years. Projected to escalate from $4.83 billion in 2024 to…
Multi-Axis Force Torque Sensor Market Forecast 2025-2034: Comprehensive Analysis …
The Multi-Axis Force Torque Sensor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Multi-Axis Force Torque Sensor Market?
In recent times, the market size for the multi-axis force torque sensor has shown substantial growth. It is projected to expand…
Evolving Market Trends In The Metal Power Transmission Chain Industry: Innovativ …
The Metal Power Transmission Chain Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metal Power Transmission Chain Market Size During the Forecast Period?
Recent years have seen a robust growth in the size of the metal power transmission chain market. Expected to…
More Releases for PDR
Global Therapeutic Landscape Of Proliferative Diabetic Retinopathy (PDR) Industr …
Overview
Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic retinopathy occurs where fragile new blood vessels form on the surface of the retina over time. These abnormal vessels can bleed or develop scar tissue causing severe loss of sight. Predisposing factors include diabetes, high blood pressure, high cholesterol, pregnancy and tobacco use. Symptoms include spots or dark strings floating in vision, vision loss, fluctuating vision,…
Proliferative Diabetic Retinopathy (PDR) Drug Pipeline Analysis and Therapeutic …
All diabetic patients are at risk of developing eye diseases is called diabetic retinopathy. The longer the patient has diabetes and the more uncontrolled it is, the greater the risk. Proliferative diabetic retinopathy is an advanced form of diabetic eye disease. In recent years, growing incidence and prevalence of diabetes, growing cases of diabetes-associated blindness, rising geriatric population across the world has positively impacted the Proliferative Diabetic Retinopathy therapeutics market. To…
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2017, provides an overview of the Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline landscape.
Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic retinopathy occurs where fragile new blood vessels form on the surface of the retina over time. These abnormal vessels can bleed or develop scar tissue…
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title India Airway Stenting Procedures Outlook to 2023 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017, provides an overview of the Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline landscape.
Proliferative diabetic retinopathy (PDR) is the most severe type of diabetic retinopathy. Proliferative diabetic…
Proliferative Diabetic Retinopathy (PDR): Pipeline Assessment of Vital Drugs & M …
In the recent times, the diabetic retinopathy therapeutic market is witnessing a bigger growth owing to the rise in a number of patients with this diabetic related ailment. To focus on this market growth, a fresh study has been included into the vast repository of online collection under Market Research Hub (MRH), and titled, ‘’Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2017‘’. The report is a complete pipeline guide…
Proliferative Diabetic Retinopathy (PDR) Market H1 2017 Pipeline Review Report
Proliferative Diabetic Retinopathy market Pipeline Review, H1 2017, provides an overview of the Proliferative Diabetic Retinopathy (Oncology) pipeline landscape. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Complete report on http://www.reportsnreports.com/reports/983989-proliferative-diabetic-retinopathy-pdr-pipeline-review-h1-2017.html
Pharmaceutical and Healthcare latest pipeline guide Proliferative Diabetic Retinopathy Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Proliferative Diabetic Retinopathy complete…
